{"id":84939,"date":"2022-06-14T20:37:47","date_gmt":"2022-06-14T17:37:47","guid":{"rendered":"https:\/\/www.technion.ac.il\/blog\/harvey-prize-ceremony-2\/"},"modified":"2022-06-14T20:37:47","modified_gmt":"2022-06-14T17:37:47","slug":"harvey-prize-ceremony-2","status":"publish","type":"post","link":"https:\/\/www.technion.ac.il\/en\/blog\/harvey-prize-ceremony-2\/","title":{"rendered":"Harvey Prize Ceremony"},"content":{"rendered":"

On June 12, the prestigious Harvey Prize was awarded to Prof. Joseph Mark DeSimone from Stanford University (Science and Technology), Prof. Raphael Mechoulam from the Hebrew University of Jerusalem (Human Health) and to Prof. James R. Rice from Harvard University (Science and Technology).<\/p>\n

\"\"<\/a><\/p>\n

In a moving ceremony hosted by Professor Asya Rolls of the Rappaport Faculty of Medicine, the three distinguished professors received their honors:<\/p>\n

Prof. Joseph Mark DeSimone<\/strong> from the Departments of Radiology and Chemical Engineering at Stanford University received the 2019-2020 award in acknowledgement of his groundbreaking work on processes to cleanly synthesize fluoropolymers, fabricate precisely defined shape-specific nanoparticles, and enable the manufacture of 3D printed objects with unprecedented speed. For these and other contributions to materials science, chemistry, nanomedicine, and 3D printing and with gratitude for his resolute commitment to translating leading-edge science into impactful solutions promoting human health and welfare.<\/p>\n

Prof. DeSimone thanked the Technion for the great honor and said that the interaction the Technion was nurturing between academia and industry is an important reflection of Leo Harvey\u2019s legacy. \u201cWe must think carefully about these ties, as not every study will receive government funding. And sometimes the solutions to these challenges are found through the support of startups and industry.\u201d<\/p>\n

Prof. Raphael Mechoulam<\/strong> from the School of Pharmacy in the Faculty of Medicine at the Hebrew University of Jerusalem received the 2019-2020 award for pioneering research into the cannabinoid system and its effects on human health, for his many discoveries that have deepened our understanding of drug abuse and provided the promise of therapy for a wide range of diseases and pathological conditions, and with gratitude for his noble contributions to humanity.<\/p>\n

Prof. Mechoulam thanked the President of the Technion and the Harvey Prize selection committee saying, \u201cIn the end, the prize is a tribute to my research group. Our findings, concerning the effect of cannabis molecules on the peripheral and central nervous system, have led to studies all over the world, which I believe will lead to the development of treatments for a wide range of diseases.\u201d<\/p>\n